Article Details

Bharat Biotech completes indigenous intranasal Covid vaccine trial - Moneycontrol

Retrieved on: 2022-08-15 11:05:37

Tags for this article:

Click the tags to see associated articles and topics

Bharat Biotech completes indigenous intranasal Covid vaccine trial - Moneycontrol. View article details on hiswai:

Excerpt

BBV154 (intra nasal vaccine) is a novel intranasal vaccine for Covid-19. It's a recombinant replication-deficient adenovirus vectored vaccine with a ...

Article found on: www.moneycontrol.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up